Mounjaro and a High Heart Rate: Making the Right Call

Why tirzepatide can push your heart rate up

GLP-1 receptor agonists, including tirzepatide, act on receptors found in the heart as well as in the gut. One consequence is a slight chronotropic effect, a technical way of saying the heart beats a little faster. This isn't unique to Mounjaro; semaglutide (Wegovy) carries the same signal. The NHS tirzepatide medicines page lists a faster heart rate among known side effects, and it appeared in SURMOUNT-1, tirzepatide's main weight-loss trial, where the increase was modest and generally did not lead people to stop treatment.

The practical picture is this: most people who notice it describe feeling their heart beating more quickly than usual, especially at rest, and you can read a detailed explanation of this effect on our page covering how Mounjaro affects heart rate. It tends to be most obvious in the first few days after a new injection or after the prescriber moves them to a higher dose. For the majority it fades within a week or two. The body's cardiovascular system adapts; the novelty wears off.

There is a second, indirect route to a raised heart rate on tirzepatide: dehydration. Nausea, vomiting and loose stools are the most common early side effects, and losing fluid volume makes the heart work harder. If you notice your heart racing and you've been struggling with GI symptoms, our page on Mounjaro and a fast heart rate covers what tends to drive this and what to do about it, including the value of drinking enough water (small, regular sips rather than large gulps). Keeping your pen in the fridge door as a reminder to take it at the same steady point each week can also reduce the variability in how your body reacts between doses.

The question is whether what you're feeling sits inside that expected pattern or outside it. The next two sections help you think that through. You can also read more about how tirzepatide interacts with the cardiovascular system on our tirzepatide and heart rate overview.

Signals that mean act now, not later

A heart rate persistently above 100 beats per minute at rest (medically termed tachycardia) crosses the line from 'side effect to monitor' into 'symptom to report'. That's true even if it started on Mounjaro. Several accompanying features raise the urgency further.

Seek prompt medical help if your raised heart rate comes with chest pain or tightness, shortness of breath at rest, dizziness or near-fainting, a fluttering or irregular sensation in the chest, or if it does not settle between doses. These are not listed as expected effects of tirzepatide; they may point to something unrelated to the medicine that needs investigating in its own right.

The MHRA's Yellow Card scheme exists so that patients and healthcare professionals can report suspected side effects from medicines. If you believe tirzepatide is causing a cardiac symptom, reporting it there contributes to the post-market safety picture for the medicine, it's worth doing even after you've spoken to a clinician.

One thing prescribers at services like ours hear regularly: people feel unsure whether a symptom is serious enough to bother a doctor with. For anything cardiac, that bar should be low. A brief call to NHS 111 costs you ten minutes. Waiting two weeks to mention it at your next review costs more. If you are already a patient elsewhere and have aftercare support, use it for exactly this kind of question, or contact our team if you're treated through us.

What your prescriber needs from you before any decision is made

The decision about what to do next (carry on and monitor, pause, adjust the dose, or investigate further) belongs with the prescriber who knows your full picture. That includes your baseline heart rate before starting treatment, any cardiac history, other medicines you take, and how your weight loss is progressing. None of those threads can be pulled in isolation.

Before your next clinical review, it helps to keep a simple record: when you notice the elevated rate, roughly how fast (if you can count it or use a smartwatch), how long it lasts, and whether anything seems to bring it on or resolve it. That information transforms a vague report into something a prescriber can actually use. Our page looking at whether Mounjaro raises heart rate sets out the clinical evidence behind this question and may help you frame the conversation with your prescriber.

If you're considering starting Mounjaro and wondering whether a pre-existing heart condition rules you out, the answer is: it depends, and a proper assessment is the only way to know. A history of arrhythmia, for example, deserves careful discussion before any GLP-1 medicine is prescribed. Our Mounjaro treatment overview covers the eligibility picture in more detail, and you can explore all weight-loss treatment options we offer through the same hub.

Tirzepatide is a prescription medicine reviewed by a real clinician before every supply, not an over-the-counter product. That clinical layer exists precisely for situations like this one: a symptom that needs a human eye, not a search engine. If you haven't yet started treatment and want to understand whether Mounjaro is appropriate for you, a free consultation with our prescribers is the right first step. The Mounjaro and heart health page goes into the broader cardiovascular evidence if you want to read further before that conversation.